News and Announcements
Approval received to continue with Human Cancer Trial
- Published November 10, 2014 1:48PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PharmaAust Limited (“PharmaAust”) (ASX:PAA &PAAO) is pleased to report that further its announcement on the 21st of October 2014, it has now received formal approval from the Royal Adelaide Hospital Research Ethics Committee to continue with its trial with PPL-1 in late stage human cancer patients.
To read the full ASX release please click on the attachment below.